Life SciencesMentor

Christine Grygon has over 25 years of scientific and leadership experience in pharmaceutical drug discovery research, development, and R&D business development, both in small molecule and protein therapeutic settings. During her time at Boehringer Ingelheim, Gyrgon has held multiple positions that were responsible for leading cross-functional/therapeutic global teams to evaluate, prioritize, and invest in early-stage licensing opportunities to drive the preclinical oncology portfolio. Now serving as the Executive Director of Business Developments and Licensing, Grygon is responsible for sourcing external innovation opportunities in support of global R&D and commercial interests. Lead external outreach /partnering visibility strategy and implementation.